Our work is entirely funded by private donations – we receive no money from government. Your money will help us continue funding research into vitiligo and supporting people affected by the condition.
CGB-600 gel for facial vitiligo
Official title: Safety and Effectiveness of CGB-600 Gel for the Treatment of Non-Segmental Facial Vitiligo: A Randomized, Double-Blind, Vehicle-Controlled Phase 1 Proof of Concept Study (Study No. CGB-600-02)
Status: Recruiting now
Description:
CAGE Bio Inc. plans to enroll about 36 participants. The experimental topical medicine is designed to reduce inflammation in vitiligo-affected skin. Researchers hope it will protect melanocytes and improve repigmentation. Possible effects may include redness, itching, burning, acne-like bumps, and infection; its full safety profile is still being studied. People ages 18 to 60 may qualify. The study is recruiting at 2 listed sites in Turkey (Türkiye).
Start date: July 25, 2025
Completion date: November 30, 2026
Organizer: CAGE Bio Inc.
Contact: Nitin Joshi, Ph.D.
Tel.: 650-996-1845
Email: njoshi@cagebio.com
Clinical Trial Alerts
Sign up and be the first to know about updates on this trial.
FAQOther Questions
- Does vitiligo increase the risk of skin cancer?
No, it does not. Despite common misconceptions, people with vitiligo are actually at a lower risk of developing skin cancer—including both nonmelanoma skin cancer (NMSC) and mal...
- Is vitiligo contagious?
Vitiligo is not contagious. This means it cannot be spread from person to person through physical contact, sharing personal items, or any other means of transmission. Vitiligo i...
- What's the status with official recognition of World Vitiligo Day?
In 2016, the United Nations marked World Vitiligo Day in its International Calendar of Disability Events. However, it was removed in 2019 when the calendar was streamlined to 'M...
Though it is not always easy to treat vitiligo, there is much to be gained by clearly understanding the diagnosis, the future implications, treatment options and their outcomes.
Many people deal with vitiligo while remaining in the public eye, maintaining a positive outlook, and having a successful career.
Copyright (C) Bodolóczki JúliaBy taking a little time to fill in the anonymous questionnaire, you can help researchers better understand and fight vitiligo.